文献速递角膜与眼表疾病青光眼

青光眼术后慢性低眼压眼行DMEK的疗效观察

Descemet Membrane Endothelial Keratoplasty in Eyes With Chronic Ocular Hypotony Following Glaucoma Surgery.
PubMed 文献 · Am J Ophthalmol · 2021-05-13

多中心回顾性病例系列纳入10眼11例DMEK手术,均为青光眼术后低眼压眼;术后3个月矫正远视力从1.52±0.68 logMAR显著改善至0.49±0.32 logMAR(P<.001)。6-12个月内皮细胞丢失60%±16%,末次随访6/11(54%)植片透明,5例于术后1-4年失败。

要点

  • 青光眼术后低眼压眼角膜水肿行DMEK可显著改善视力
  • 6-12个月内皮细胞丢失达60%±16%,远期植片失败率较高
  • 术后眼压多不超过13 mm Hg,2例降至1 mm Hg,需警惕低眼压加重

核心结论

  • DMEK是治疗青光眼术后低眼压眼角膜水肿的有效术式,患者可从视力改善中获益。

研究设计与样本

  • 多中心回顾性病例系列,2013年1月至2019年7月在以色列2个中心和加拿大1个中心纳入青光眼术后低眼压眼,共10眼11例DMEK手术。

主要发现

  • 矫正远视力从术前1.52±0.68 logMAR改善至术后3个月0.49±0.32 logMAR(P<.001)。
  • 11例手术中3例(27%)发生再次气泡注入(rebubbling)。
  • 术后6-12个月内皮细胞丢失60%±16%(范围41%-89%)。
  • 末次随访6/11(54%)植片透明,其余5例于术后1-4年失败。

关键数值与推荐

  • DMEK指征包括7例人工晶状体眼大泡性角膜病变、2例DMEK失败、1例DSAEK失败。
  • 术前眼压5.1±1.6 mm Hg(范围1-7 mm Hg);除1例外术后眼压未升至13 mm Hg以上,2例术后1年眼压降至1 mm Hg。

临床怎么用

  • 对青光眼术后低眼压合并角膜水肿者, DMEK可改善视力,但需告知内皮细胞丢失大、远期植片失败风险高。
  • 术后应密切监测眼压,警惕眼压进一步降低至1 mm Hg。

局限性

  • 回顾性设计、样本量小(10眼11例手术),随访时间不等,缺乏对照,结论需更大样本验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To assess the outcomes of Descemet membrane endothelial keratoplasty (DMEK) in patients with ocular hypotony after glaucoma surgery. DESIGN: retrospective case series. METHODS: Setting: Multicenter retrospective case series. PATIENTS/INTERVENTION: Hypotonic eyes with prior glaucoma surgery that underwent DMEK between January 2013 and July 2019 in Israel (2 centers) and Canada (1 center). MAIN OUTCOME MEASURES: Pre/postoperative corrected distance visual acuity, complications, 3- to 6-month endothelial cell loss, and intraocular pressure (IOP). RESULTS: The study included 11 DMEK procedures performed in 10 eyes of 4 males and 6 females aged 65-84 years. Indications for DMEK included 7 cases of pseudophakic bullous keratopathy, 2 cases of failed DMEK, and 1 case of failed Descemet stripping automated endothelial keratoplasty. All patients had at least 1 previous trabeculectomy operation. One patient had 2 trabeculectomy procedures and 1 tube placement procedure. Two patients had 1 previous trabeculectomy and 1 tube placement procedure. The corrected distance visual acuity improved significantly from 1.52 ± 0.68 logarithm of minimal angle of resolution preoperatively to 0.49 ± 0.32 logarithm of minimal angle of resolution 3 months postoperatively (P < .001). Rebubbling occurred in 3 of 11 procedures (27%). Endothelial cell loss 6-12 months postoperatively was 60% ± 16% (range, 41%-89%). At the last follow-up visit, 6 of 11 (54%) of the grafts were clear. The remaining 5 grafts failed at 1-4 years postoperatively. The preoperative IOP was 5.1 ± 1.6 mm Hg (range, 1-7 mm Hg). In all but one patient, the postoperative IOP did not increase to more than 13 mm Hg. In 2 cases, the IOP decreased from 5 and 7 mm Hg preoperatively to 1 mm Hg 1 year postoperatively. CONCLUSION: DMEK is a valid procedure for the treatment of corneal edema in hypotonic eyes after glaucoma procedures. These eyes benefit from improvement in vision after DMEK.

来源:Am J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Livny E, Mimouni M, Sorkin N, et al. Descemet Membrane Endothelial Keratoplasty in Eyes With Chronic Ocular Hypotony Following Glaucoma Surgery. Am J Ophthalmol. 2021. PMID: 33991516. doi:10.1016/j.ajo.2021.04.034

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。